Evotec and Sanofi Collaborate on Infectious Disease R&D Initiative
Sanofi SA and Evotec AG have teamed up to form an infectious disease research and development program. Source: BioSpace
Cyteir Therapeutics Nabs $29 Million and a New CEO
Cyteir Therapeutics snagged $29 million and a new chief executive officer as the company pushes forward to develop small-molecule inhibitors in the fight against cancer. Source: BioSpace
Pfizer Terminates PDC Agreement with CytomX Therapeutics
This week Pfizer notified the Bay Area-based company of its intent to terminate its five-year-old oncology collaboration. Source: BioSpace
Health Insurer Cigna Paying $67 Billion to Buy Express Script
U.S. insurer Cigna is acquiring pharmacy benefits manager Express Scripts for approximately $67 billion. Source: BioSpace
Juno Therapeutics Spinout Raises $90M
JW Therapeutics, a clinical stage biopharma company founded by Juno Therapeutics and WuXi AppTec Group, has closed a Series A financing worth $90 million. Source: BioSpace
Clinical Trial Startup Process Takes Longer Than 10 Years Ago, Tufts CSDD Reports
The process of selecting clinical trial sites and launching studies, beginning with site identification and ending with study start-up completion, takes an average of 31.4 weeks, a full month longer…
Former FDA Official Shares Tips for Data Integrity Compliance
As part of its heightened focus on data integrity the FDA has increased the sophistication of its inspections to identify hard-to-find data violations, according to a former CDER official who…
Chicago Sues Opioid Distributors as McCaskill Accuses Teva of Stonewalling Investigation
Investigations and lawsuits against opioid manufacturers and distributors continued as Sen. Claire McCaskill (D-Mo.) accused a drugmaker of blocking a Senate investigation and the city of Chicago sued three distributors.…
Gottlieb Says Contracting System Is ‘Rigged’ Against Biosimilars
FDA Commissioner Scott Gottlieb called the drug contracting system “rigged” in remarks Wednesday at the America’s Health Insurance Plans National Health Policy Conference in Washington, D.C. Source: Drug Industry Daily
Seattle Genetics Commences Dosing in Early-Stage Multiple Myeloma Trial
Seattle Genetics dosed its first patient with an early-stage treatment for patients with relapsed or refractory multiple myeloma (MM). Source: BioSpace
- Go to the previous page
- 1
- …
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- …
- 610
- Go to the next page